Xenon Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-48.1M | $-50.8M | $2.6M | $5.7M |
| FY2021 | $-69.5M | $-71.6M | $2.1M | $10.0M |
| FY2022 | $-101.0M | $-103.9M | $2.9M | $20.4M |
| FY2023 | $-151.1M | $-156.7M | $5.6M | $32.4M |
| FY2024 | $-181.4M | $-184.5M | $3.1M | $50.7M |